3,560 material Form 8-K filings that 2,489 companies we cover made with the SEC in October 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). 2,508 of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Sunshine Biopharma (SBFM) closed a best-efforts public offering on October 9, 2026, with gross proceeds of approximately $6.0 million before placement agent fees and other expenses. The offering included Series D warrants with a $0.66 exercise price, which the company says could bring up to about $14.4 million more if fully exercised, though no assurance is given that any warrants will be exercised.
Common units sold at $0.55 each, with each unit including one share of common stock and two Series D warrants exercisable at $0.66 per share over five years.
Placement agent Aegis Capital Corp. received a 7% fee on the public offering price plus a 1% non-accountable expense allowance.
The company expects to use net proceeds for general corporate purposes and working capital.
The offering was made under a Form S-1 (File No. 333-299274) declared effective on October 7, 2026.
On October 9, 2026, Flyte Aviation agreed to sell 2,050 shares of Series C-4 Convertible Preferred Stock to existing investors for $2.05 million, with closing expected on or about October 13, 2026. The same day, the company cut the conversion price of its Series C, Series D and Series J preferred stock from $2.30 to $1.00 per share (Series J was reduced to $1.00), which could increase the number of common shares issuable to those holders and may dilute existing shareholders.
2,050 Series C-4 preferred shares at a $1,000 stated value, for $2.05 million in gross proceeds; Dawson James Securities acted as placement agent
Series C-4 shares convertible at $1.00 per share into up to 2,050,000 shares of common stock
Conversion price cut from $2.30 to $1.00 for Series C-1, C-2, C-3, C-4 and Series D preferred stock, with the floor price waived
Series J conversion price reduced to $1.00; the company effected a 1-for-10 reverse stock split on October 5, 2026
Arrive AI agreed on October 5, 2026 to sell 384,615 shares and matching warrants to one accredited investor for $250,000, with the deal closing the same day. The 8-K corrects an October 6 press release that described the sale as a registered direct offering; the company says it was an unregistered private placement, and it must file a resale registration statement within 20 days of closing.
Price of $0.65 per share and accompanying warrant for 384,615 shares; aggregate purchase price $250,000; closed October 5, 2026
Warrant exercisable immediately at $0.70 per share, expires October 5, 2031, and may be exercised on a cashless basis at 3.33 shares per share otherwise issuable
Correction: the October 6, 2026 press release called the deal a registered direct offering; the filing says it was a PIPE exempt from registration under Section 4(a)(2) and Rule 506 of Regulation D
Company must file a Form S-3 resale registration within 20 days after closing; no placement fee is payable and proceeds are for general working capital
Volato Group, Inc. (the filing names this company, not SOAR AI, Inc.) signed an equity line of credit with DFU, LLC that lets it sell up to $1,000,000,000 of Class A common stock over 36 months, at its own discretion. The deal also requires issuing 3,646,974 common shares and 13,058 Series B preferred shares convertible into 56,528,082 common shares, which would dilute existing shareholders.
Up to $1,000,000,000 of Class A common stock may be sold to DFU, LLC over a 36-month Investment Period, at the company's discretion.
Each Put Notice may cover up to $6,000,000 in shares, with a floor price of $0.21 per share.
Commitment Shares: 3,646,974 common shares plus 13,058 Series B preferred shares convertible into 56,528,082 common shares, subject to NYSE American approval.
Without stockholder approval, sales cannot exceed 19.99% of outstanding shares as of October 8, 2026.
Quantum Cyber N.V. entered a sales agreement on October 9, 2026 with Titan Partners Securities LLC to sell up to $100,000,000 of its ordinary shares through an at-the-market offering. The company is not obligated to sell any shares, and it pays the agent a 3.0% commission on gross sales, so the program could add new shares outstanding and dilute existing shareholders if used.
Program size: up to $100,000,000 of ordinary shares, sold through Titan Partners Securities LLC as sales agent
Agent commission: 3.0% of gross sales price, plus reimbursement of certain specified expenses
Intended use of proceeds includes capital expenditures and software development for its motor, propeller and quantum antenna lines, and working capital
Shares are issued under a Form S-3 shelf registration declared effective by the SEC on June 15, 2026
Niki BioSolutions entered into an at-the-market offering agreement allowing it to sell up to $1,396,000 of common stock through H.C. Wainwright & Co. and Brookline Capital Markets, under a shelf registration declared effective on October 9, 2026. The company has no obligation to sell any shares, and any sales would dilute existing shareholders and carry a 3.0% placement fee to Wainwright.
Maximum aggregate offering price of up to $1,396,000 of common stock, subject to authorized share availability and Form S-3 eligibility
Placement fee of 3.0% of gross sales price paid to Wainwright on shares sold as sales agent
Wainwright is deemed to have a conflict of interest because its managing director, Dr. Kira Sheinerman, is the Company's largest shareholder and a director; Brookline acts as qualified independent underwriter for no additional compensation
SINTX Technologies called its Class B warrants, and holders exercised 941,423 warrant shares at $2.14 per share, producing $2,014,645.22 in gross proceeds. The remaining Class B warrants expired unexercised, and no Class B warrants are now outstanding, while the company had 7,558,073 common shares outstanding as of October 9, 2026.
Gross proceeds of $2,014,645.22 from funded exercises and exchanges covering 941,423 Class B warrant shares at $2.14 per share; call period expired 5:00 p.m. Eastern Time on October 8, 2026
Issued 651,204 shares of common stock, plus pre-funded warrants for 290,219 shares to accommodate 9.99% beneficial ownership limits
Remaining 941,423 Class B warrants expired without consideration; Class A warrants were unaffected
Common shares outstanding were 7,558,073 as of close of business October 9, 2026
i3 Verticals, LLC, a subsidiary of i3 Verticals, Inc., entered into an Amended and Restated Credit Agreement on October 9, 2026, replacing its prior credit agreement dated May 8, 2023. The filing describes a $350 million senior secured revolving facility with JPMorgan Chase Bank, N.A. as administrative agent, with pricing tied to the company's net leverage ratio and financial covenants that include a minimum interest coverage ratio of 3.00 to 1.00 and a maximum net leverage ratio of 4.00 to 1.00.
Replaces the Borrower's prior credit agreement dated May 8, 2023, which was amended over time
Provides $350 million of aggregate revolving commitments, secured by first-priority interests in substantially all assets
Permits additional commitments of the greater of $100 million or 100% of consolidated EBITDA for the last four quarters
Covenants require interest coverage of at least 3.00 to 1.00 and net leverage of no more than 4.00 to 1.00
On October 9, 2026, Vaxcyte closed the sale of $575 million of 1.50% convertible senior notes due 2032, including an over-allotment option exercised in full, and a separate equity offering of 7,412,500 shares at $64.00 each plus pre-funded warrants. The filing reports net proceeds of approximately $558.7 million from the notes and $544.3 million from the equity offering, and notes that conversion of the notes would be settled in cash, shares, or a mix at Vaxcyte's election, which could dilute shareholders if shares are issued.
Convertible notes: $575 million principal, 1.50% interest, maturing October 15, 2032, with an initial conversion price of approximately $89.60 per share
Equity offering: 7,412,500 shares at $64.00 per share plus 400,000 pre-funded warrants, with a 1,171,875-share option exercised in full on October 7, 2026
Approximate net proceeds: $558.7 million from the notes and $544.3 million from the equity offering, after underwriting discounts and expenses
Both offerings were underwritten by Jefferies LLC and Leerink Partners LLC and closed on October 9, 2026
On October 9, 2026, T Stamp entered an Equity Distribution Agreement with Maxim Group LLC, allowing the company to sell common stock through Maxim as sales agent or principal. The offering covers up to $5,323,474 of shares under a prospectus supplement, and the company is not obligated to sell any shares. Shareholders could face dilution if the company sells shares under the program.
Maxim receives a commission of 3.0% of aggregate gross proceeds from each share sale, plus reimbursement of certain expenses up to $40,000 in aggregate and up to $3,000 quarterly for counsel fees.
The ATM prospectus covers up to $5,323,474 of common stock, subject to the Form S-3 registration statement declared effective April 30, 2026 and baby shelf limits.
The company is not required to sell any shares, and either party may terminate the agreement on 15 days written notice.
On October 5, 2026, Hydrofarm entered into a mutual release agreement settling all claims related to an engagement between the parties. As part of the deal, the company agreed, subject to certain milestones, to issue 300,000 non-voting convertible preferred shares, which would convert into 300,000 shares of common stock once stockholders approve the issuance as required by Nasdaq rules. The filing also furnishes an investor presentation posted October 7, 2026, but gives no financial results.
Agreement and mutual release dated October 5, 2026 settles all claims related to the parties' engagement
Company agreed to issue 300,000 non-voting convertible preferred shares, subject to certain milestones
Preferred shares convert into 300,000 common shares only after stockholder approval under Nasdaq rules
Investor presentation posted October 7, 2026 and furnished as Exhibit 99.1
Saratoga Investment Corp. and its subsidiary SIF II amended the Valley National Bank credit facility on October 8, 2026, raising available borrowings from $85.0 million to $110.0 million and allowing commitment increases up to $135.0 million over the first two years. The amendment also loosens concentration limits for healthcare and the three largest obligors and replaces Henri Steenkamp with Christine Ramdihal as Key Person.
Borrowings available under the Valley Credit Facility rise from $85.0 million to $110.0 million.
Permitted commitment increases during the first two years rise from $100.0 million to $135.0 million, subject to terms and a customary fee.
Healthcare concentration limit rises from 25.0% to 35.0% of Aggregate ECA Value; three largest obligors limit rises from 30.0% to 35.0%.
Christine Ramdihal replaces Henri Steenkamp as Key Person under the agreement.
Digital Realty Trust sold €1.0 billion of 5.125% guaranteed senior unsecured notes due October 9, 2036, through a finance subsidiary, with the parent and operating partnership guaranteeing the debt. Net proceeds were about €985.8 million, which the company intends to use for green projects, debt repayment and general corporate purposes. The filing adds a new long-term debt obligation but does not report earnings or guidance.
Issue size: €1.0 billion of notes sold at 99.289% of principal, maturing October 9, 2036
Interest at 5.125% per year, payable each October 9 starting October 9, 2027
Net proceeds of approximately €985.8 million, to be allocated to Eligible Green Projects or used for other general purposes
On October 5, 2026, Ares Commercial Real Estate Corporation amended its master repurchase facilities with Citibank, Morgan Stanley Bank, and Wells Fargo Bank. The amendments reduce the minimum tangible net worth the company must maintain under each facility from $500 million to $400 million, and the Wells Fargo facility also adds 80% of net proceeds from future equity issuances. The filing does not disclose borrowing amounts under the facilities.
Amendments dated October 5, 2026, cover the Citibank, Morgan Stanley Bank, and Wells Fargo Bank facilities.
Minimum tangible net worth requirement under each facility reduced from $500 million to $400 million.
Wells Fargo facility adds 80% of net proceeds from future equity issuances to the requirement.
Universal Safety Products, Inc. (the filing names this company, not DeFi Capital Markets or DCM as the request stated) entered into an amended and restated securities purchase agreement on October 9, 2026 with SJC Lending LLC for up to $2.5 million in convertible note financing. Conversion shares above 19.99% of common stock require new stockholder approval, and the notes convert at a discount to recent trading prices, which would dilute existing shareholders.
Up to $2,650,000 in convertible notes for up to $2.5 million; $1,000,000 funded June 12, 2026 and $500,000 funded July 29, 2026, with a third $1,000,000 tranche due after a resale registration statement is declared effective
Conversion price is the greater of a $1.00 floor or 80% of the lowest five-day VWAP, capped at $10.00 per share; conversions above 19.99% of shares outstanding need stockholder approval
Notes accrue 8% interest (20% after an event of default) and mature one year after issuance; the company may not enter a variable rate transaction for one year and SJC holds a one-year right of first refusal on future equity offerings
McGraw Hill's subsidiary completed a $400 million offering of 8.000% senior secured notes due 2033 and $930 million of term loans on October 9, 2026, using the proceeds to redeem its 5.750% notes due 2028 and refinance its existing term loan. The company said the transactions extend debt maturities and reduce the revolver's interest rate, and that it continues to reduce gross debt. The filing reports no earnings or guidance figures, so the effect on profitability is not stated.
$400 million of 8.000% senior secured notes due 2033 issued by McGraw-Hill Education, Inc., with interest payable January 15 and July 15 starting July 15, 2027
$930 million A&E Term Loan Facility maturing October 7, 2033, bearing interest at SOFR plus 2.75%
Revolving credit facility commitments set at $150 million and extended to October 9, 2031
On September 30, 2026, the company prepaid $50 million of term loan principal
Gray Media amended its senior credit facility on October 9, 2026, increasing Term Loan G by $75 million to $675 million, with proceeds and cash on hand expected to fund the redemption of $150 million of its 10.500% senior secured notes due 2029 on October 19, 2026. The redemption is conditioned on funding of the added loan, which is expected by October 19, 2026, and after the transactions Gray expects $200 million of 2029 notes to remain outstanding.
The $75 million incremental Term Loan G brings its principal to $675 million and is due July 15, 2030, with delayed draw availability expected on or before October 19, 2026.
$150 million of 2029 notes would be redeemed on October 19, 2026 at 105.250% of principal, plus accrued and unpaid interest, if the loan funds.
Term Loan G bears interest at Term SOFR plus 3.50% or the base rate plus 2.50%, with quarterly principal reductions of 0.25% of the initial principal amount.
Gray expects $200 million of 2029 notes outstanding after the transactions.
DENTSPLY SIRONA obtained lender consent and amended its revolving credit facility and three note purchase agreements, effective around September 30, 2026. The changes raise the maximum permitted leverage ratios for the quarters ending September 30 and December 31, 2026, and add tighter limits on new liens, subsidiary debt and restricted payments. The company says the revised terms are intended to keep it in compliance with its debt covenants in all material respects.
Maximum permitted Total Leverage Ratio and Senior Leverage Ratio increased for fiscal quarters ending September 30, 2026 and December 31, 2026.
Until the compliance certificate for fiscal 2026 is delivered, new liens and new subsidiary debt are generally prohibited, and restricted payments are limited with certain carveouts.
Credit facility adds a new pricing level for the applicable margin and facility fee; note interest increases if leverage meets specified thresholds.
INNOVATE Corp. entered into a supplemental indenture requiring it to redeem all of its 9.5% Convertible Senior Secured Notes due 2027 after the lock-up on stock it received in the DBMG Global sale ends. The redemption price is 100% of principal plus accrued and unpaid interest, and the amendment removes any obligation to make a repurchase offer, which ties the debt repayment to the timing of the lock-up expiration.
All Convertible Notes are to be redeemed on the 15th business day after the lock-up period ends.
Redemption price is 100% of principal plus accrued and unpaid interest to, but excluding, the redemption date.
The lock-up expires on the earlier of December 4, 2026 or the date a resale registration statement for the DBMG stock consideration is deemed effective.
The supplemental indenture is dated October 9, 2026, amends the indenture dated August 4, 2025, and is signed by CFO Michael J. Sena.
Atmos Energy completed a public offering of $700 million in 6.000% senior notes maturing November 15, 2036, on October 9, 2026, under a registration statement on Form S-3. The company received net proceeds of approximately $691.4 million after the underwriting discount and estimated offering expenses, adding to its debt obligations. The notes are unsecured and rank equally with its other unsubordinated debt, and the indenture contains covenants limiting certain liens, sale-leaseback transactions, mergers and asset sales.
Principal amount of $700 million; coupon of 6.000% per year, paid May 15 and November 15, starting May 15, 2027
Net proceeds of approximately $691.4 million after underwriting discount and estimated offering expenses
Notes mature November 15, 2036; company may redeem them at its option under the indenture's terms
Indenture covenants limit specified liens, sale-leaseback transactions, consolidations or mergers, and sales of substantially all assets
Cheetah Net Supply Chain Service Inc. agreed on October 7, 2026 to sell 100,000 shares of Class B common stock to CEO and Chairman Huan Liu at $3.30 per share, and the deal closed on October 9, 2026. The company received $330,000 in gross proceeds, and the shares were issued as restricted securities in a private placement. The filing gives no use of proceeds, and the amount is small relative to the deal's scope, so its effect on shareholders appears limited.
Purchaser: Huan Liu, the company's CEO, director and Chairman, who is also listed as interim CFO in the signature block
Terms: 100,000 Class B common shares at $3.30 per share, for $330,000 in aggregate gross proceeds
Agreement dated October 7, 2026; transaction closed October 9, 2026
Shares issued privately under Regulation S and/or Section 4(a)(2) and Rule 506(b) of Regulation D
Lucid Group drew $400 million under its Delayed Draw Term Loan facilities on October 6, 2026, from an affiliate of the Public Investment Fund. Total principal outstanding under the facility is now about $2.1 billion, with about $400 million of remaining borrowing capacity.
Draw of $400 million made on October 6, 2026 under the existing DDTL agreement with Ayar Third Investment Company
Aggregate principal outstanding under the DDTL is approximately $2.1 billion after the draw
Approximately $400 million of additional borrowing capacity remains available
Key loan terms are incorporated by reference from 8-K filings dated August 5, 2024, November 5, 2025 and April 14, 2026
Mangoceuticals sold 657,000 shares of common stock, each paired with a warrant, in a registered direct offering to certain investors, for gross proceeds of about $492,750, with closing on October 9, 2026. The unit price was a 74% premium to the referenced recent closing price of $0.43, but the warrants can add up to 788,400 shares and may dilute existing shareholders.
657,000 shares sold at $0.75 per share and accompanying warrant, for gross proceeds of about $492,750 before offering expenses
Warrants exercisable at $1.00 per share, immediately exercisable, expiring five years from issuance, covering up to 788,400 shares
Unit price represents an approximately 74% premium to the referenced recent closing share price of $0.43; no placement agent was engaged
Proceeds intended for working capital and general corporate purposes; separate $2.5 million MangoRx IP subsidiary investment does not involve parent-company shares
On October 9, 2026, subsidiary STAR Investment Holdings SPV LLC entered into Amendment No. 5 to its margin loan with Morgan Stanley, which had about $46.5 million outstanding before the amendment. The amendment lowers the share price trigger that would require mandatory prepayment from $10.00 to $8.00 for the Safehold common stock pledged as collateral, and it ends a $15.8 million undrawn delayed draw commitment. Because the lower trigger and loan-to-value changes affect when collateral and repayment obligations apply, shareholders should note the changed terms on the loan secured by Safehold shares.
Share price trigger for mandatory prepayment cut from $10.00 to $8.00 per Safehold common share
Delayed draw commitment of up to $15.8 million terminated; it was undrawn at the amendment date
Loan had about $46.5 million principal outstanding before Amendment No. 5, secured by a first priority pledge of Safehold shares
Amendment also lowers loan-to-value ratios that trigger additional collateral posting or permit collateral release requests
Navan disclosed that a wholly owned subsidiary entered into a revolving warehouse credit facility of up to $225 million with Barclays Bank PLC as administrative agent, to finance purchases of the company's corporate charge card receivables. As of the filing date no advances had been made, and the company also amended a separate 2022 receivables facility with Goldman Sachs Bank USA to prepay Class B advances.
Up to $225 million revolving facility under a 2026 Credit Agreement dated October 5, 2026, with Barclays Bank PLC as administrative agent
Facility has a 24-month revolving period and a three-month amortization period; borrowings are secured by a first-priority interest in the receivables
No advances had been made as of the filing date
Omnibus Amendment dated October 5, 2026 lets Liquid Labs prepay all outstanding Class B advances under the 2022 Credit Agreement with Goldman Sachs Bank USA as administrative agent
Altria Group entered into an agreement effective October 7, 2026, to extend its $3.0 billion senior unsecured revolving credit facility. The expiration date moves from October 24, 2029 to October 24, 2030, and all other terms remain in effect. The filing describes a routine extension of existing borrowing capacity rather than a change in the company's financial position.
On October 5, 2026, authID entered into an agreement to sell $1,350,000 of senior secured convertible debentures and warrants to four accredited investors, and the offering closed on October 6, 2026. The debentures carry no interest, mature on February 28, 2027 or earlier upon a change of control, and are secured by substantially all company assets, while the holders of the April 2026 debentures agreed to extend their own maturity to the same date. For shareholders, the conversion and warrant terms could add significant share dilution and the new secured debt ranks alongside the April 2026 debentures.
Gross proceeds of $1,350,000 from the offering, before placement agent fees and expenses, closed October 6, 2026.
Debentures convert at $0.386 per share into an aggregate of 3,497,409 shares and mature February 28, 2027.
Warrants cover 1,800,000 shares at $0.50 per share and cannot be exercised until stockholder approval is obtained.
April 2026 debenture maturity moved from October 29, 2026 to February 28, 2027, with the warrant exercise price cut from $0.57 to $0.50.
Gray Media entered into a seventh amendment to its senior credit agreement on October 8, 2026, adding a new $600 million Term Loan G maturing July 15, 2030. The company also cut its revolving credit facility from $750 million to $680 million and extended that facility's maturity from December 1, 2028 to July 15, 2030. The filing describes the deal as refinancing that extends debt maturities, and it adds secured borrowing at a 3.50% margin over Term SOFR.
New $600 million Term Loan G matures July 15, 2030, with a 3.50% margin over Term SOFR and a 0.25% quarterly principal reduction
Term Loan G proceeds repaid part of the Term D Loan, leaving $150 million outstanding due December 1, 2028
Revolving credit facility reduced from $750 million to $680 million and extended to July 15, 2030
Press release states the Term Loan G was issued at an original issue discount of 0.5%
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.